Bedoya H. Jose's most recent trade in Surmodics, Inc. was a trade of 30,008 Common Stock done . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 30,008 | 0 (0%) | 0% | - | Common Stock | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 4,674 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 4,218 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 3,853 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 3,555 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 2,964 | 0 | - | - | Employee Stock Options (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 2,605 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. | 14 Feb 2025 | 5,275 | 34,232 (0%) | 0% | 27.3 | 144,008 | Common Stock |
| Surmodics Inc | Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,275 | 0 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.10 per share. | 14 Feb 2025 | 4,224 | 30,008 (0%) | 0% | 34.1 | 144,038 | Common Stock |
| Surmodics Inc | Jose Bedoya H. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. | 08 Feb 2024 | 3,932 | 30,108 (0%) | 0% | 23.9 | 94,171 | Common Stock |
| Surmodics Inc | Bedoya H. Jose | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 3,932 | 0 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 3,853 | 3,853 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Bedoya H. Jose | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.89 per share. | 08 Feb 2024 | 2,954 | 27,154 (0%) | 0% | 31.9 | 94,203 | Common Stock |
| Surmodics Inc | Bedoya H. Jose | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,803 | 28,957 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 4,674 | 4,674 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 1,984 | 26,176 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale of securities on an exchange or to another person at price $ 34.89 per share. | 28 Nov 2022 | 4,366 | 24,192 (0%) | 0% | 34.9 | 152,321 | Common Stock |
| Surmodics Inc | Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 4,366 | 0 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.18 per share. | 28 Nov 2022 | 4,366 | 28,558 (0%) | 0% | 20.2 | 88,106 | Common Stock |
| Surmodics Inc | Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,555 | 3,555 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,375 | 24,192 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 30 Nov 2021 | 5,576 | 28,393 (0%) | 0% | 21.3 | 118,825 | Common Stock |
| Surmodics Inc | Jose H. Bedoya | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 5,576 | 0 | - | - | Stock Option (right to buy) | |
| Surmodics Inc | Jose H. Bedoya | Director | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 30 Nov 2021 | 5,576 | 22,817 (0%) | 0% | 44.0 | 245,350 | Common Stock |